Please login to the form below

Not currently logged in
Email:
Password:

Encap begins construction of encapsulation plant

Scottish drug delivery company Encap begins construction of a new plant in Scotland to meet increased demand for its contract encapsulation services

Scottish drug delivery company Encap has begun construction of a new plant in Scotland to meet increased demand for its contract encapsulation services.

Encap says it will invest GBP 3m (USD 6.1m) in the new production facility, which will increase manufacturing capacity by up to 60 per cent.

The new site should be operational by June 2008, added the company.

Encap specialises in formulating high-potency cytotoxic compounds, which it then encapsulates using three proprietary sustained-release technologies: DuoCap, LayerCap and Abusolve. The technologies control when and where in the body the drug will be released.

Encap says that liquid-fill encapsulation is one of the fastest growing sectors of the drug delivery market, increasing at an annual rate of 10 to 30 per cent. The burgeoning biologics market is also responsible for growth, as vulnerable small molecule and protein-based drugs are protected by encapsulation as they pass down the alimentary canal.

Encap's customer base includes small biotechs to large pharmaceutical companies looking to reformulate existing products to extend their lifecycle. Currently, Encap is partnering with an unnamed US pharma client for a generic product which will soon be submitted to the FDA for accreditation.

3rd September 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics